PROBODY Platform

Advertisement

cGxPJobs Banner

Innovent’s IBI343 Shows Strong Efficacy in Phase III Study, Eyes Regulatory Approval

SAN FRANCISCO and SUZHOU, China, June 4, 2026 Innovent Biologics has announced a major breakthrough in precision oncology as...

By cGxPwire Editor
June 5, 2026

Read More

CytomX and Regeneron Expand $4B Cancer Immunotherapy Alliance

SOUTH SAN FRANCISCO, California, USA, June 3, 2026 CytomX Therapeutics has announced a significant expansion of its strategic research...

By cGxPwire Editor
June 5, 2026

Read More

Advertisement

cGxPJobs

Directory